Literature DB >> 24441847

[Oxidative stress in bipolar affective disorder].

E Z Reininghaus1, S Zelzer, B Reininghaus, N Lackner, A Birner, S A Bengesser, F T Fellendorf, H-P Kapfhammer, H Mangge.   

Abstract

The results of mortality studies have indicated that medical conditions, such as cardiovascular disease, obesity and diabetes are the most important causes of mortality among patients with bipolar disorder. The reasons for the increased incidence and mortality are not fully understood. Oxidative stress and an inadequate antioxidative system might be one missing link and could also help to further elucidate the pathophysiological basis of bipolar disorder. This article provides a comprehensive review of oxidative stress in general and about the existing data for bipolar disorder. In addition information is given about possible therapeutic strategies to reduce oxidative stress and the use in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24441847     DOI: 10.1007/s00115-013-3962-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  39 in total

1.  The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia.

Authors:  F M Benes; D Matzilevich; R E Burke; J Walsh
Journal:  Mol Psychiatry       Date:  2006-03       Impact factor: 15.992

2.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

Review 3.  Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force.

Authors:  O Traub; B C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

4.  A meta-analysis of oxidative stress markers in schizophrenia.

Authors:  Ming Zhang; ZhongMing Zhao; Lin He; ChunLing Wan
Journal:  Sci China Life Sci       Date:  2010-02-12       Impact factor: 6.038

5.  Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells.

Authors:  Sung Woo Park; Chan Hong Lee; Jung Goo Lee; Luck Woo Kim; Bae Sub Shin; Bong Ju Lee; Young Hoon Kim
Journal:  Neurosci Res       Date:  2011-01-14       Impact factor: 3.304

6.  Peripheral biomarkers and illness activity in bipolar disorder.

Authors:  Flávio Kapczinski; Felipe Dal-Pizzol; Antonio Lucio Teixeira; Pedro V S Magalhaes; Márcia Kauer-Sant'Anna; Fábio Klamt; José Claudio F Moreira; Mateus Augusto de Bittencourt Pasquali; Gabriel Rodrigo Fries; João Quevedo; Clarissa Severino Gama; Robert Post
Journal:  J Psychiatr Res       Date:  2010-06-11       Impact factor: 4.791

7.  Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia.

Authors:  Meena Arvindakshan; Madhav Ghate; Prabhakar K Ranjekar; Denise R Evans; Sahebarao P Mahadik
Journal:  Schizophr Res       Date:  2003-08-01       Impact factor: 4.939

8.  Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.

Authors:  Jun-Feng Wang; Li Shao; Xiujun Sun; L Trevor Young
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

9.  The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode.

Authors:  Salih Selek; Haluk A Savas; H Serdar Gergerlioglu; Feridun Bulbul; Efkan Uz; Mehmet Yumru
Journal:  J Affect Disord       Date:  2007-09-14       Impact factor: 4.839

Review 10.  Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness.

Authors:  Michael Berk; Olivia Dean; Hemmo Drexhage; John J McNeil; Steven Moylan; Adrienne O'Neil; Christopher G Davey; Livia Sanna; Michael Maes
Journal:  BMC Med       Date:  2013-03-18       Impact factor: 8.775

View more
  1 in total

Review 1.  Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications.

Authors:  Ellen F Charles; Christophe G Lambert; Berit Kerner
Journal:  Int J Bipolar Disord       Date:  2016-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.